This topic contains a solution. Click here to go to the answer

Author Question: Cognitive scientists have shown that an individual's ability to evaluate risks and rewards A) ... (Read 102 times)

ap345

  • Hero Member
  • *****
  • Posts: 537
Cognitive scientists have shown that an individual's ability to evaluate risks and rewards
 
  A) increases steadily across the lifespan.
  B) increases until a person is in her mid-20s.
  C) increases until the end of adolescence, then begins to decay.
  D) is well developed by mid-adolescence.

Question 2

Cognitive scientists have shown that an individual's ability to focus her attention increases
 
  A) steadily throughout the lifespan.
  B) until middle adulthood, then starts to decay.
  C) until about age 20.
  D) in specific, discrete stages.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

miss.ashley

  • Sr. Member
  • ****
  • Posts: 371
Answer to Question 1

B

Answer to Question 2

C




ap345

  • Member
  • Posts: 537
Reply 2 on: Jun 22, 2018
Excellent


miss.ashley

  • Member
  • Posts: 371
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

It is important to read food labels and choose foods with low cholesterol and saturated trans fat. You should limit saturated fat to no higher than 6% of daily calories.

Did you know?

Although puberty usually occurs in the early teenage years, the world's youngest parents were two Chinese children who had their first baby when they were 8 and 9 years of age.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library